CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 242 filers reported holding CYTOKINETICS INC in Q1 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $70,690,596 | -9.7% | 2,399,545 | 0.0% | 3.33% | +9.6% |
| Q2 2023 | $78,273,158 | -7.3% | 2,399,545 | 0.0% | 3.04% | -18.5% |
| Q1 2023 | $84,439,989 | -23.2% | 2,399,545 | 0.0% | 3.73% | -5.3% |
| Q4 2022 | $109,947,152 | -7.9% | 2,399,545 | -2.7% | 3.94% | -8.9% |
| Q3 2022 | $119,430,000 | +23.3% | 2,465,016 | 0.0% | 4.32% | +16.9% |
| Q2 2022 | $96,850,000 | +6.7% | 2,465,016 | 0.0% | 3.70% | +8.9% |
| Q1 2022 | $90,737,000 | -19.2% | 2,465,016 | 0.0% | 3.39% | -11.3% |
| Q4 2021 | $112,355,000 | -0.5% | 2,465,016 | -22.0% | 3.82% | +15.2% |
| Q3 2021 | $112,928,000 | +191.8% | 3,159,701 | +61.6% | 3.32% | +173.8% |
| Q2 2021 | $38,702,000 | +8.3% | 1,955,612 | +27.3% | 1.21% | +11.2% |
| Q1 2021 | $35,736,000 | +77.1% | 1,536,373 | +58.2% | 1.09% | +53.7% |
| Q4 2020 | $20,181,000 | – | 971,151 | – | 0.71% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |